Work

Regression of Sight-Threatening Macular Edema in Type 2 Diabetes Following Treatment With the Anti–Tumor Necrosis Factor Monoclonal Antibody Infliximab

Year: 2005

Type: article

Source: Diabetes Care

DOI: 10.2337/diacare.28.2.445

Authors: Petros P. Sfikakis, Nikos Markomichelakis, George P. Theodossiadis, Vlassis Grigoropoulos, Nikos Katsilambros, Panayiotis G. Theodossiadis

Institutions: Laiko General Hospital of Athens, General Hospital of Athens G. Genimatas, National and Kapodistrian University of Athens

Language: English

Topic: Retinal Diseases and Treatments

Subfield: Ophthalmology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2150239642

FWCI: 4.891

Cites: 16

Cited by: 92

Related to: 10